How is the UK political landscape evolving and what does this mean for Health Technology and Medical Device innovators? On Friday 28th July, Robert Hull (Senior Consultant – NHS Insight...
Read More
In this webinar, we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director – Mtech Access) speaks to Dr Stefan Walzer (CEO, President &...
Read More
In the second episode of our Global Whispers webinar series, we explored market access for digital therapeutics. Clare Foy (Global Market Access Director – Mtech Access) spoke to Shefali Shah...
Read More
What does it take to bring a cannabinoid pharmaceutical to market? On Tuesday 23rd May Clare Foy (Global Market Access Director – Mtech Access) was joined by Michael Sassano (CEO...
Read More
What are surrogate endpoints and how can they support the accelerated approval of new medicines? Where and how are surrogate endpoints being used? In which disease areas and markets can...
Read More
How will changes to the structure of primary care impact decision making? How is the relationship between Integrated Care Boards (ICBs) and primary care stakeholders evolving? How will funding flows...
Read More
Is data the key to transforming healthcare systems and patient care? What are the top priorities for digital transformation leaders in the NHS? How can Pharma and Medtech companies partner...
Read More
We answer audience questions from our NHS Whispers webinar on the economics of healthcare and the NHS
How and where can innovation drive improvements in care and deliver better health for the population? How is the NHS looking to collaborate with key partners across industry and academia?...
Read More
Will NHS leaders, as part of an Integrated Care System (ICS), make conscious decisions to drive economic and social change? What social and economic value do ICSs offer the wider...
Read More
